ChAdOx1 nCoV-19
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ChAdOx1 nCoV-19, covering 2020-11-27 to 2021-09-28. Get the full timeline:
Most recent: Clinical Trial Update: EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19 [Phase 2, Phase 3]